Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reducing falls and improving mobility in multiple sclerosis.
Natalizumab-induced hepatic injury: A case report and review of literature.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Long-term daily vibration exposure alters current perception threshold (CPT) sensitivity and myelinated axons in a rat-tail model of vibration-induced injury.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
Bone health and multiple sclerosis.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
Development of a high-resolution fat and CSFsuppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.
Alemtuzumab treatment of multiple sclerosis.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Socioeconomic status. The relationship with health and autoimmune diseases.
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
[Non-medicinal treatments of spasticity in multiple sclerosis].
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.

Pages